The Batman Stack – Retatrutide 10 mg + Tesamorelin 10 mg + MOTS-c 10 mg + KLOW 80 mg
Exploring Metabolic, Cellular Energy & Tissue-Repair Pathways
Product Highlights
-
4-piece research bundle
-
Retatrutide 10 mg – GLP-1, GIP and glucagon receptor signalling
-
Tesamorelin 10 mg – Growth hormone-releasing hormone and GH/IGF-1 pathways
-
MOTS-c 10 mg – Cellular energy regulation and metabolic signalling
-
KLOW 80 mg – GHK-Cu, BPC-157, TB-500 and KPV research blend
-
-
Compounds investigated individually across weight regulation, visceral fat, metabolic function and tissue biology
-
A research collection spanning distinct biological mechanisms
-
Supplied strictly for research purposes
Why the Batman Stack?
Metabolic regulation, cellular energy and tissue maintenance involve multiple biological pathways.
Retatrutide is investigated for weight regulation and metabolic effects, while tesamorelin acts through growth hormone-releasing hormone pathways and has a specific prescription use for reducing excess abdominal fat in adults with HIV-associated lipodystrophy.
MOTS-c is studied for mitochondrial signalling and metabolic adaptation. The individual components of KLOW are explored across collagen, tissue repair and inflammatory signalling.
Together, these materials offer a research comparison of different mechanisms. Their inclusion in one bundle does not establish compatibility, combined efficacy, muscle preservation or synergy.
Key Research Areas
⚖️ Weight Regulation – Investigating retatrutide’s effects on appetite, body weight and metabolic signalling
🔬 Visceral Adipose Tissue – Exploring tesamorelin’s effects in specific clinical populations
⚡ Cellular Energy – Studying MOTS-c and mitochondrial-associated metabolic pathways
🧬 Skin & Collagen Biology – Investigating GHK-Cu and extracellular matrix processes
🔄 Tissue Repair & Inflammatory Signalling – Exploring the individual components of KLOW
🧪 Comparative Research – Examining distinct metabolic and tissue-related mechanisms
How It Works
-
Retatrutide is an investigational GLP-1, GIP and glucagon receptor agonist. Clinical trials have demonstrated substantial weight reduction in adults with obesity. These findings concern the trial medicine used under controlled conditions and do not establish outcomes for this bundle.
-
Tesamorelin is a synthetic growth hormone-releasing hormone analogue that stimulates growth hormone release and increases IGF-1. Prescription tesamorelin is indicated for reducing excess abdominal fat in adults with HIV-associated lipodystrophy. This does not establish general weight-loss or muscle-preservation benefits.
-
MOTS-c is a naturally occurring mitochondrial-derived peptide investigated for metabolic signalling, cellular stress responses and exercise-associated pathways. Much of the treatment evidence comes from cell and animal studies; benefits from administration in humans remain unproven.
-
KLOW combines GHK-Cu, BPC-157, TB-500 and KPV. Its individual ingredients are explored for collagen biology, tissue repair, cell migration and inflammatory signalling. Evidence varies by ingredient, and findings for thymosin β4 should not automatically be attributed to TB-500. The blend’s clinical benefits and safety are not established.
The combined effects, safety and potential synergy of all four products have not been established in controlled human trials.
Storage Instructions
-
Follow the product-specific storage instructions supplied with each item.
-
Protect from excessive heat and direct light.
-
Follow validated research protocols for solvent selection, preparation and storage after reconstitution.
-
Do not assume the products can be mixed or stored together.
Purity & Quality
Refer to the batch-specific certificate of analysis, where available, for identity, purity and testing information.
For KLOW, consult the product documentation for the exact component quantities and blend specification.
These products are supplied as research materials. Research-grade designation does not establish safety or suitability for human use.
Disclaimer
For research use only.
Not intended for human consumption or medical use.
Educational information only. “Batman Stack” is an informal name, not an established clinical protocol. The combined effects, safety and potential synergy of retatrutide, tesamorelin, MOTS-c and KLOW have not been established in controlled human trials.
Findings from individual compounds do not establish benefits for the combined bundle.
“Exploring the science of metabolism, cellular energy and tissue biology.”